Based on the biochemical function we and others revealed, we previously proposed that enhancer malfunction may serve as the underlying mechanisms and driving force for the aggressive behaviors of tumor cells bearing MLL3 or MLL4 mutations, which have been corroborated in human cancer cell lines and murine genetic models of multiple cancers32–36. Here, KMT2D is linked to cancer.